Hospital Sultanah Bahiyah
Alor Star, Kedah 5460
2 studies enrolling now · 19 studies all time
What they study most
Acute Myocardial Infarction (AMI), Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer, Beta-Thalassemia, Beta-thalassemia, CIED Related Infection, Cardiovascular Risk, Chronic Kidney Disease, Crohn Disease, Diabetes Mellitus, Diabetes Mellitus, Type 2, Erythrocyte Transfusion, Gastroparesis
Studies at this site
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity — Recruiting now
- A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials — Recruiting now
- ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
- A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation — Running, not enrolling
- ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
- Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2) — Running, not enrolling
- A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
- A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer — Running, not enrolling
- A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes — Completed
- LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) — Running, not enrolling
- An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
- An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia — Completed
- Effects of Oral Sildenafil on Mortality in Adults With PAH — Stopped early
- A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03 — Stopped early
- Diabetic Gastroparesis Study 05 — Stopped early
- A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04 — Stopped early
- A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01 — Stopped early
- World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
- Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early